HIV Medicine
Publisher: Wiley · ISSN 14642662 · 66 articles
- Adiposity profiles in relation to cardiometabolic disease risk in South African adults with HIV on long‐term antiretroviral therapy
-
Mental health care utilization among young black sexual minority men living with HIV at Ryan‐white funded HIV care centers in Atlanta, Georgia
Abstract Introduction Young Black sexual minority men (YB‐SMM) living with HIV experience disproportionate mental health burdens, exacerbated by systemic inequities, stigma and structural determinants. Despite high rates of mental...
-
Immune outcomes with dolutegravir‐based dual therapy versus bictegravir‐based triple therapy: A multinomial propensity score analysis
Abstract Objectives To compare immune outcomes after switching to dolutegravir/lamivudine (DTG/3TC), dolutegravir/rilpivirine (DTG/RPV) and bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF). Methods Three Spanish cohorts of...
- Beyond borders: Making HIV prevention and care work for people on the move
-
HIV/AIDS burden in South Asia, 1990–2023: Temporal trends, sex differences and attributable risk factors from the Global Burden of Disease study 2023
Abstract Objectives To describe levels and trends of the HIV/AIDS burden in the Global Burden of Disease (GBD) South Asia region and its five countries, 1990–2023, including sex differences and risk‐attributable burden. Methods We...
-
Estimating the potential need for HIV pre‐exposure prophylaxis in Italy: A national modelling study
Abstract Objectives Despite the expanding implementation of HIV pre‐exposure prophylaxis (PrEP) across Europe, substantial gaps in access and uptake remain. We aimed to estimate the size and distribution of the population potentially...
-
Pregnancy and neonatal outcomes after prenatal exposure to dolutegravir: Data from a European cohort collaboration
Abstract Objective We aimed to assess ‘real‐world’ pregnancy and neonatal outcomes following prenatal dolutegravir (DTG) use in a European setting. Methods We conducted a pooled analysis of individual‐patient data from seven...
-
Structural determinants of outcomes related to the prevention of vertical HIV transmission: A cross‐country ecological analysis
Abstract Objective This study examined the longitudinal associations of epidemiological, health system and structural factors with paediatric HIV infections and antiretroviral therapy (ART) need among pregnant women in 30 high‐burden...
-
Applying the CONSENSUS‐LAI virological failure definition in real‐world practice: Evidence from the multicentre LAHIV cohort
Abstract Objectives Definitions of virological failure (VF) for long‐acting cabotegravir plus rilpivirine (CAB+RPV) remain inconsistent across real‐world cohorts. The CONSENSUS‐LAI Delphi process (September 2025) set a shared plasma...
-
Impact of the coronavirus disease 2019 (COVID‐19) pandemic and stringency index on the dispensation of human immunodeficiency virus post‐exposure prophylaxis in Brazil: A retrospective study
Abstract Introduction The coronavirus disease 2019 (COVID‐19) pandemic substantially affected healthcare systems worldwide and may have compromised access to human immunodeficiency virus (HIV) prevention strategies, including...
-
Beyond HIV prevention: Reframing PrEP clinics as hubs for viral hepatitis prevention and elimination
Abstract Objectives The expansion of HIV pre‐exposure prophylaxis (PrEP) has created a growing network of prevention services that regularly engage people who may also be exposed or susceptible to viral hepatitis. PrEP care is...
-
In vitro NAD+ supplementation increases CD4+ and CD8+ T cell function in people with HIV
Abstract Objectives HIV perturbs T cell homeostasis and disrupts immune function, increasing the risk of age‐associated comorbidities. Ageing people with HIV (PWH) have exacerbated expression of CD38 on T cells, which depletes...
-
Prevalence of metabolic syndrome and classification performance of triglyceride‐glucose‐derived indices in people living with HIV in Spain
Abstract Objectives Estimate the prevalence and predominant phenotypic patterns of metabolic syndrome (MetS) in people living with HIV receiving contemporary antiretroviral therapy (ART) in southeastern Spain, identify independently...
- Late HIV diagnosis: An application of flexible Bayesian approaches to understand associated factors and time to diagnosis in Ireland, 2015–2024
- Clinical management of pregnancy, delivery and breastfeeding in women living with HIV in Italy: A survey of participating infectious diseases centres
- Association of delayed ART initiation with mortality according to documented concurrent clinical conditions in adults with HIV: A multicentre cohort study
- Stability of the HIV cascade of care throughout the COVID‐19 pandemic in Europe: Results from the multinational EuroSIDA cohort study (2016–2022)
- Preparing for pregnancy while living with HIV: An exploratory qualitative study of Women's preconception information needs and priorities
- Dietary counselling and exercise training for lipid management in people living with HIV: A systematic review and meta‐analysis
- The effect of a tailored dietary intervention on serum biomarkers and faecal microbiome composition in people with HIV at risk of cardiovascular disease
- Wellbeing of trans and gender‐diverse people with HIV in the United Kingdom: Results from Positive Voices 2022
- HIV‐related knowledge and stigma among healthcare workers in Greece: A secondary analysis of a European survey
- Real‐world use and effectiveness of fostemsavir in a US clinical setting: Insights from Trio Health HIV Research Network
- Medication burden and prescribing quality in older people living with HIV: Associations with quality of life
- Quality of life among older adults with HIV after switching to bictegravir‐based three‐drug or dolutegravir‐based two‐drug regimens
- Assessing the impact, barriers and facilitators of peer‐driven interventions on the prevention of mother‐to‐child transmission of HIV in low‐ and middle‐income countries: A systematic review and meta‐analysis
- HIV‐associated nephropathy: A decade of clinical outcomes, global disparities and emerging promise
- Issue Information
- CROI 2026—A summary from the BHIVA CROI Working Group
-
Prevalence of many comorbidities is similar irrespective of the time since HIV diagnosis in persons ageing with HIV who have survived to age 65 years
Abstract Objective To compare the prevalence of comorbidity in persons with HIV ≥65 years of age based on the time from HIV diagnosis. Design Cross‐sectional observational cohort study. Methods Data was collected from 540 participants...